Mediaspace scheduled maintenance: Aug 25, 2026 07:00 - 12:00 AM. During this time, videos will be temporarily unavailable. Check status updates.

Home

Publication

Antibiotic Rifaximin for Treatment of Chronic Liver Disease-Induced HE: A Longitudinal In Vivo 1H-MRS Study of Brain Metabolism on BDL Rats

Rolf Gruetter, Cristina Ramona Cudalbu Moldovan, Emmanuelle Ines Flatt, Stefanita-Octavian Mitrea
2019
Conference Papers

Official source

About
Privacy
Disclaimer

Graph Chatbot

Rolf Gruetter, Cristina Ramona Cudalbu Moldovan, Emmanuelle Ines Flatt, Stefanita-Octavian Mitrea
2019
Conference Papers

Official source

Related publications (3)

https://infoscience.epfl.ch/entities/publication/03f01106-244c-450a-8da3-f8bccb110c69

About this result

This page is automatically generated and may contain information that is not correct, complete, up-to-date, or relevant to your search query. The same applies to every other page on this website. Please make sure to verify the information with EPFL's official sources.

Related publications (3)

The Slc25a47 locus is a novel determinant of hepatic mitochondrial function implicated in liver fibrosis

Johan Auwerx, Kristina Schoonjans, Alessia Perino, Xiaoxu Li, Hao Li, Hadrien Charles Edouard Demagny, Yu Sun, Vera Monica Lemos Da Silva, Francesca Pontanari, Nadia Bresciani

Background & Aims: Transporters of the SLC25 mitochondrial carrier superfamily bridge cytoplasmic and mitochondrial metabolism by channeling metabolites across mitochondrial membranes and are pivotal for metabolic homeostasis. Despite their physiological r ...

ELSEVIER2022

Abnormal brain oxygen homeostasis in an animal model of liver disease

Cristina Ramona Cudalbu Moldovan, Dunja Simicic, Katarzyna Pierzchala

Background & Aims: Increased plasma ammonia concentration and consequent disruption of brain energy metabolism could underpin the pathogenesis of hepatic encephalopathy (HE). Brain energy homeostasis relies on effective maintenance of brain oxygenation, an ...

ELSEVIER2022

SMN Depleted Mice Offer a Robust and Rapid Onset Model of Nonalcoholic Fatty Liver Disease

Bernard Schneider

BACKGROUND & AIMS: Nonalcoholic fatty liver disease (NAFLD) is considered a health epidemic with potential devastating effects on the patients and the healthcare systems. Current preclinical models of NAFLD are invariably imperfect and generally take a lon ...

2021